BMS-509744 is a selective, ATP-competitive Itk inhibitor with an IC50 of 19 nM. It inhibits IL-8 expression and HIV infection, ameliorates pulmonary inflammation in allergic asthma mouse models, and reduces Imiquimod-induced skin inflammation in mice.
Molekulargewicht:
623.83
Reinheit:
0.997
CAS Nummer:
[439575-02-7]
Formel:
C32H41N5O4S2
Target-Kategorie:
Others|||Tyrosine Kinases|||HIV Protease|||IL Receptor|||Immunology/Inflammation related
T14674
T14674
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten